221 related articles for article (PubMed ID: 16624955)
1. Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain.
Labuz D; Berger S; Mousa SA; Zöllner C; Rittner HL; Shaqura MA; Segovia-Silvestre T; Przewlocka B; Stein C; Machelska H
J Neurosci; 2006 Apr; 26(16):4350-8. PubMed ID: 16624955
[TBL] [Abstract][Full Text] [Related]
2. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
[TBL] [Abstract][Full Text] [Related]
3. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
4. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
5. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
[TBL] [Abstract][Full Text] [Related]
6. Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray.
Terashvili M; Tseng LF; Wu HE; Narayanan J; Hart LM; Falck JR; Pratt PF; Harder DR
J Pharmacol Exp Ther; 2008 Aug; 326(2):614-22. PubMed ID: 18492947
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue.
Schäfer M; Carter L; Stein C
Proc Natl Acad Sci U S A; 1994 May; 91(10):4219-23. PubMed ID: 7910403
[TBL] [Abstract][Full Text] [Related]
8. The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse.
Tseng LF
Jpn J Pharmacol; 2002 Jul; 89(3):216-20. PubMed ID: 12184724
[TBL] [Abstract][Full Text] [Related]
9. Persistent inflammatory pain decreases the antinociceptive effects of the mu opioid receptor agonist DAMGO in the locus coeruleus of male rats.
Jongeling AC; Johns ME; Murphy AZ; Hammond DL
Neuropharmacology; 2009; 56(6-7):1017-26. PubMed ID: 19265713
[TBL] [Abstract][Full Text] [Related]
10. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
Zhou L; Zhang Q; Stein C; Schäfer M
J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
[TBL] [Abstract][Full Text] [Related]
11. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
Schmidt BL; Tambeli CH; Levine JD; Gear RW
Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
[TBL] [Abstract][Full Text] [Related]
12. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
14. Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain.
Mousa SA; Bopaiah PC; Stein C; Schäfer M
Pain; 2003 Dec; 106(3):297-307. PubMed ID: 14659512
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin.
Stein C; Gramsch C; Herz A
J Neurosci; 1990 Apr; 10(4):1292-8. PubMed ID: 2158530
[TBL] [Abstract][Full Text] [Related]
16. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells.
Brack A; Rittner HL; Machelska H; Leder K; Mousa SA; Schäfer M; Stein C
Pain; 2004 Dec; 112(3):229-238. PubMed ID: 15561377
[TBL] [Abstract][Full Text] [Related]
17. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression.
Brack A; Rittner HL; Machelska H; Shaqura M; Mousa SA; Labuz D; Zöllner C; Schäfer M; Stein C
Pain; 2004 Mar; 108(1-2):67-75. PubMed ID: 15109509
[TBL] [Abstract][Full Text] [Related]
18. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
19. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
Gouardères C; Jhamandas K; Sutak M; Zajac JM
Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of β-endorphin in docosahexaenoic acid-induced antinociception.
Nakamoto K; Nishinaka T; Ambo A; Mankura M; Kasuya F; Tokuyama S
Eur J Pharmacol; 2011 Sep; 666(1-3):100-4. PubMed ID: 21658380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
